---
category: news
title: "Antengene and MindRank AI Enter into Collaboration to Advance the Development of Difficult-to-Drug Molecular Targets"
excerpt: "This collaboration marks the establishment of a synergistic alliance between a leading research-driven biopharmaceutical company and an innovative AI-powered drug discovery company to transform drug discovery and development."
publishedDateTime: 2021-08-09T00:38:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/antengene-and-mindrank-ai-enter-into-collaboration-to-advance-the-development-of-difficult-to-drug-molecular-targets-1030704495"
webUrl: "https://markets.businessinsider.com/news/stocks/antengene-and-mindrank-ai-enter-into-collaboration-to-advance-the-development-of-difficult-to-drug-molecular-targets-1030704495"
type: article
quality: 44
heat: 44
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1578775/English_Logo.jpg"
    width: 400
    height: 253
    isCached: true

secured: "yaYTln6Sp6ScUlVoy9jiFX5BrNyF+VXTuYzJW9obEFrUDbBODjqdBTpxepGjVSTNGSp8XTUcjxKbXY/AtRGA61Q1pqHIrTF1OQK7Go9oDV7Mgp42Uhq2z752Mh0MJvLJL9L48NJmmEWgM8YQbzbrS0eCnRWbp/lrGYXxc39NL2cVa9/97WKfu++ytYCgDSTqGjXLsxFo8pZVYgD4H80DhmfttOHOIBoPknrgp5X7wnVCgHDkxM3zvZ6B6vljEx4qgq7YS4abTmWgHrIkEaA+oV46cNSpn9XWCrGSFfYWWe4ixrcEGOD5psYl4XubynDRQsUDN+/ggg6zjYhMWAEFnHehnAnhgIrdNIAmDN30Hz8=;P8AQLvD190chp6Ii4yspRw=="
---

